As 2023 ends, we would like to thank you for reading the Eloquest Healthcare Blog! We hope you have found our posts during the last 12 months to be both informative and impactful to your professional career. Here are some of the past year’s most liked posts that we invite you to visit…
In ‘Hospital Onset Bacteremia (HOB): Let’s Talk About Reporting’ Guest Author, Michelle DeVries, MPH, CIC, VA-BC, CPHQ, FAPIC shares insight about the potential future of Bacteremia Reporting and what this means for you and your facility. For several years there has been a lot of chatter about potential future expansion of bloodstream infection surveillance to move beyond only Central Line-Associated Bloodstream infections (CLABSI) and expand to include all hospital onset bacteremia (HOB). As this gets closer to being a reality for programs, it is important to understand what this does and does not mean. Learn more here!
In “Nurses Love Tape But It Can Be A Sticky Situation to Remove It” we address how too much of a good thing can lead to an under-recognized healthcare acquired condition: MARSI ‘Medical Adhesive-Related Skin Injury’. When it comes to medical adhesives, too much of a good thing can result in MARSI, including skin tears and epidermal stripping. MARSI is a serious healthcare-acquired condition that affects patients of all ages, particularly the elderly, obese, diabetic, and anyone with sensitive or fragile skin. Read more here!
In ‘Vascular Access Device Pistoning: The Problem and Solution’, guest author Michelle (Mickey) Hawes, RN, DNP, CRNI, VA-BC, ACRP-CP addresses the causes and risks of Vascular Access Device (VAD) pistoning and the solution to eliminate it. To learn the latest about what pistoning is, how to recognize it and how to avoid complications caused by it click here!
It was a great year for virtual education opportunities! This year we focused on Mobile Vascular Access, Vascular Access Team Development, and Monetizing Your Worth. Check out our on demand educational webinar library here!
Looking forward to 2024, we are excited to lead and share the constant change and improvements taking place in the realms of hospital quality, patient safety and HAI reduction! Make sure to subscribe to the Eloquest Healthcare Blog below so you don’t miss out on career excelling content in the year ahead. For more information about Mastisol®, Detachol® and SecurAcath®, please contact your Eloquest Healthcare® sales consultant, or request a follow-up here.
